Patents-Review.com
ClassID:

170479 ⎘

G01N2333/7051 - CPC Classification

Classification description:

Assays involving biological materials from specific organisms or of a specific nature from animals; from humans; Assays involving receptors, cell surface antigens or cell surface determinants; Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3 T-cell receptor (TcR)-CD3 complex

Recent Application in this class:
#1
20260146073
2026-05-28

T CELL RECEPTORS TARGETING MUTATED CDKN2A

 #2
20260116966
2026-04-30

DEVELOPMENT AND USE OF NOVEL MULTISPECIFIC TUMOR INHIBITOR

 #3
20260092918
2026-04-02

Molecular Tension Probes and Methods to Determine or Monitor the Efficacy of Cancer and Other Immune Therapies

 #4
20260055207
2026-02-26

HETERODIMERIC PROTEIN PRODUCTION METHOD, DIMERIC PROTEIN, MONOMERIC PROTEIN, AND TARGET RESPONSIVE HETERODIMERIC PROTEIN SCREENING METHOD

 #5
20260035460
2026-02-05

COMBINATION THERAPY WITH ANTI-PVRIG ANTIBODIES FORMULATIONS AND ANTI-PD-1 ANTIBODIES

 #6
20260018250
2026-01-15

COMPUTATIONAL GENERATION OF ARTIFICIAL PROTEINS WITH PROGRAMMABLE IMMUNOGENICITY

 #7
20260008832
2026-01-08

HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12R MUTATION

 #8
20250353912
2025-11-20

COMPOSITIONS AND METHODS COMPRISING ANTIBODIES THAT BIND TO COVALENT PEPTIDE CONJUGATES

 #9
20250347693
2025-11-13

T Cell Receptor Identification

 #10
20250340637
2025-11-06

CD3 TARGETING ANTIBODIES AND USES THEREOF

 #11
20250340611
2025-11-06

ANTI-KRAS-G12D T CELL RECEPTORS

 #12
20250334578
2025-10-30

CD123 AND CD200 AS MARKERS FOR THE DIAGNOSIS AND IMMUNE-ERADICATION OF LEUKEMIC STEM CELLS (LSCS)

 #13
20250333505
2025-10-30

T-CELL RECEPTOR CONSTANT REGION 1 ANTIBODY OR T-CELL RECEPTOR CONSTANT REGION 2 ANTIBODY

 #14
20250321228
2025-10-16

MICROIMPRINTING OF ANTIBODIES AND BIOMOLECULES FOR CELL PHENOTYPING AND ACTIVATION

 #15
20250306022
2025-10-02

METHOD FOR CLASSIFYING CELLS

 #16
20250304687
2025-10-02

MULTISPECIFIC ANTIBODIES TARGETING CD79B/CD3 AND THE USES THEREOF

 #17
20250295696
2025-09-25

T-CELL TARGET DISCOVERY

 #18
20250290843
2025-09-18

METHODS AND SYSTEMS FOR PREDICTING SINGLE CELL TRANSCRIPTOMIC INFORMATION FROM FLOW CYTOMETRY DATA

 #19
20250277013
2025-09-04

T CELL RECEPTOR DERIVED BINDING POLYPEPTIDES

 #20
20250270640
2025-08-28

ANTIGEN REACTIVE T-CELL RECEPTORS

 #21
20250231186
2025-07-17

COUPLING ASSAY FOR T CELL SPECIFICITY (CATS) AND METHOD OF ITS USE

 #22
20250223358
2025-07-10

NOVEL ANTI-CD3 ANTIBODIES AND USES THEREOF

 #23
20250216381
2025-07-03

Methods for Identifying Neoantigen-Reactive T Cell Receptors

 #24
20250179575
2025-06-05

Liquid Biopsy Analysis of Cellular States to Predict Immunotherapy Toxicity

 #25
20250164501
2025-05-22

BIOCHEMICAL ASSAYS FOR THERAPEUTIC PROTEINS

 #26
20250154494
2025-05-15

Microfluidic Co-Encapsulation Device and System and Methods for Identifying T-Cell Receptor Ligands

 #27
20250140344
2025-05-01

T CELL RECEPTOR SCREENING METHODS

 #28
20250130222
2025-04-24

IDENTIFICATION OF COMMON TUMOR-SPECIFIC T CELL RECEPTORS AND ANTIGENS

 #29
20250127814
2025-04-24

BOREALIN TARGETING POLYPEPTIDES FOR DETECTION AND TREATMENT OF CANCER

 #30
20250116673
2025-04-10

METHODS TO DETERMINE CD4+ MEMORY T CELL RESPONSES TO SARS-COV-2 INFECTION OR VACCINATION

 #31
20250093354
2025-03-20

METHOD FOR HIGH THROUGHPUT PEPTIDE-MHC AFFINITY SCREENING FOR TCR LIGANDS

 #32
20250067738
2025-02-27

STATISTICAL ANALYSIS OF THE OVARIAN TUMOR IMMUNE MICROENVIRONMENT USING MULTIPLEX IMMUNOFLUORESCENCE

 #33
20250044293
2025-02-06

PERSONALIZED RANKING AND IDENTIFICATION OF ONCO-REACTIVE T CELL RECEPTORS AND USES THEREOF

 #34
20250044288
2025-02-06

CELLULAR ASSAYS AND METHODS TO ASSESS MHC-PEPTIDE-TCR INTERACTIONS AND KINETICS

 #35
20250027941
2025-01-23

METHODS OF ASSAYING MICRO-OBJECTS IN A MICROFLUIDIC DEVICE

 #36
20250020556
2025-01-16

CHROMATOGRAPHIC ISOLATION OF CELLS AND OTHER COMPLEX BIOLOGICAL MATERIALS

 #37
20250019406
2025-01-16

SORTING WITH COUNTER SELECTION USING SEQUENCE SIMILAR PEPTIDES

 #38
20240415919
2024-12-19

COMPOSITIONS AND METHODS FOR TREATMENT OF AUTOIMMUNE DISORDERS AND CANCER

 #39
20240408138
2024-12-12

INCENP TARGETING POLYPEPTIDES FOR DETECTION AND TREATMENT OF CANCER

 #40
20240374644
2024-11-14

HERV-K ANTIBODY THERAPEUTICS

 #41
20240360216
2024-10-31

ANTI-CD3 HUMANIZED ANTIBODY

 #42
20240343799
2024-10-17

ANTI-CD79BxCD3 BISPECIFIC ANTIBODY AND USE THEREOF

 #43
20240331862
2024-10-03

SCREENING METHOD AND INDENDITIES OF BIOMARKERS FOR DIFFERENTIAL DIAGNOSIS OF PARKINSONISM AND/OR COGNITIVE IMPAIRMENT

 #44
20240327911
2024-10-03

ANTIGEN REACTIVE T-CELL RECEPTORS

 #45
20240327491
2024-10-03

T CELL RECEPTORS SPECIFIC FOR TUMOR-ASSOCIATED ANTIGENS AND METHODS OF USE THEREOF

 #46
20240319207
2024-09-26

METHOD FOR IDENTIFYING T-CELL EPITOPE SEQUENCE, AND APPLICATION OF SAME

 #47
20240294602
2024-09-05

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

 #48
20240293454
2024-09-05

TCR-T CELL FOR KILLING TUMORS, AND PREPARATION METHOD THEREFOR AND USE THEREOF

 #49
20240272171
2024-08-15

Methods for Identification of Exchangeable MHC Binding Peptides and Methods of Use Thereof

 #50
20240261396
2024-08-08

TOLEROGENIC SYNTHETIC NANOCARRIERS FOR ALLERGY THERAPY

 #51
20240242353
2024-07-18

Validation Methods for Multiplexed Imaging Method

 #52
20240239864
2024-07-18

HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST CD22

 #53
20240238341
2024-07-18

NEUROPROTECTIVE COMPOSITIONS AND METHODS

 #54
20240226257
2024-07-11

ANTIBODIES THAT BIND THE TUMOR (T) ANTIGEN OF MERKEL CELL POLYOMAVIRUS AND RELATED DIAGNOSTICS

 #55
20240210404
2024-06-27

METHODS FOR PREDICTING THE RISK OF LYMPH NODE METASTASIS AND/OR RECURRENCE OF PATIENTS SUFFERING FROM A T1 CANCER TREATED BY ENDOSCOPIC RESECTION

 #56
20240209086
2024-06-27

THERAPEUTIC ANTIBODIES

 #57
20240209059
2024-06-27

ANTI-KRAS-G12D T CELL RECEPTORS

 #58
20240168025
2024-05-23

HEMATOPOIETIC CELL PHENOTYPING USING CIRCULATING CELL-FREE MARKERS

 #59
20240166751
2024-05-23

HLA-RESTRICTED EPITOPES ENCODED BY SOMATICALLY MUTATED GENES

 #60
20240156955
2024-05-16

TOLEROGENIC SYNTHETIC NANOCARRIERS

 #61
20240131132
2024-04-25

ANTIBODIES THAT BIND THE TUMOR (T) ANTIGEN OF MERKEL CELL POLYOMAVIRUS AND RELATED DIAGNOSTICS

 #62
20240125793
2024-04-18

LIGAND DISCOVERY FOR T CELL RECEPTORS

 #63
20230417743
2023-12-28

ANTIBODY-LINKED IMMUNO-SEDIMENTATION AGENT AND METHOD OF ISOLATING A TARGET FROM A SAMPLE USING SAME

 #64
20230408524
2023-12-21

Reagent composition for detection of non-hematopoietic tumor and use thereof

 #65
20230408523
2023-12-21

METHODS OF IDENTIFYING GAMMA DELTA T CELL-MODULATING AGENTS

 #66
20230374101
2023-11-23

SCREENING AND ANTITUMOR USE OF KRAS MUTATION SPECIFIC T CELL RECEPTOR

 #67
20230366891
2023-11-16

METHODS AND COMPOSITIONS FOR IN SITU IMMUNE PROFILING OF HEART TRANSPLANT BIOPSIES

 #68
20230348563
2023-11-02

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

 #69
20230340066
2023-10-26

Anti-human papillomavirus 16 E6 T cell receptors

 #70
20230321225
2023-10-12

TOLEROGENIC SYNTHETIC NANOCARRIERS TO REDUCE IMMUNE RESPONSES TO THERAPEUTIC PROTEINS

 #71
20230321224
2023-10-12

TOLEROGENIC SYNTHETIC NANOCARRIERS TO REDUCE ANTIBODY RESPONSES

 #72
20230310593
2023-10-05

TOLEROGENIC SYNTHETIC NANOCARRIERS FOR ALLERGY THERAPY

 #73
20230265158
2023-08-24

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

 #74
20230235016
2023-07-27

PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

 #75
20230235015
2023-07-27

PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

 #76
20230235014
2023-07-27

PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

 #77
20230220087
2023-07-13

Use of Bispecific CD123 x CD3 Diabodies for the Treatment of Hematologic Malignancies

 #78
20230213514
2023-07-06

Methods for isolating target cells from blood

 #79
20230203127
2023-06-29

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

 #80
20230151076
2023-05-18

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

 #81
20230113246
2023-04-13

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

 #82
20230094867
2023-03-30

ANTI-IDIOTYPIC ANTIBODIES AGAINST ANTI-CD79B ANTIBODIES

 #83
20230089465
2023-03-23

T CELL RECEPTORS RECOGNIZING MHC CLASS II-RESTRICTED MAGE-A3

 #84
20230088740
2023-03-23

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

 #85
20230087025
2023-03-23

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

 #86
20230077903
2023-03-16

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

 #87
20220389406
2022-12-08

COMPOSITIONS AND METHODS FOR T-CELL RECEPTOR IDENTIFICATION

 #88
20220354947
2022-11-10

METHODS FOR PROVIDING POLYMERIC SYNTHETIC NANOCARRIERS FOR GENERATING ANTIGEN-SPECIFIC TOLERANCE IMMUNE RESPONSES

 #89
20220332785
2022-10-20

T CELL RECEPTORS RECOGNIZING R175H OR Y220C MUTATION IN P53

 #90
20220306742
2022-09-29

Anti-T-cell nanobody and nucleic acid encoding sequence thereof, and uses of the same

 #91
20220291215
2022-09-15

METHODS OF IDENTIFYING T CELL RECEPTORS

 #92
20220252594
2022-08-11

GAMMA-DELTA T CELL LIGANDS FOR CANCER IMMUNOTHERAPY

 #93
20220236276
2022-07-28

METHODS FOR MODULATING A TREATMENT REGIMEN

 #94
20220229067
2022-07-21

Ligand discovery for T cell receptors

 #95
20220213168
2022-07-07

Peptides and combination of peptides for use in immunotherapy against various tumors

 #96
20220089677
2022-03-24

Anti-KRAS-G12D T cell receptors

 #97
20220089673
2022-03-24

HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12R MUTATION

 #98
20220088135
2022-03-24

METHODS OF MAKING AND USING SOLUBLE MHC MOLECULES

 #99
20220065856
2022-03-03

AFFINITY-OLIGONUCLEOTIDE CONJUGATES AND USES THEREOF

 #100
20220041690
2022-02-10

Peptides and combination of peptides for use in immunotherapy against various tumors

 #101
20220041689
2022-02-10

Peptides and combination of peptides for use in immunotherapy against various tumors

 #102
20220034899
2022-02-03

ANTIBODY QUANTIFICATION IN BIOLOGICAL SAMPLES

 #103
20220033469
2022-02-03

Peptides and combination of peptides for use in immunotherapy against various tumors

 #104
20220017598
2022-01-20

Peptides and combination of peptides for use in immunotherapy against various tumors

 #105
20220017595
2022-01-20

Peptides and combination of peptides for use in immunotherapy against various tumors

 #106
20220009995
2022-01-13

Peptides and combination of peptides for use in immunotherapy against various tumors

 #107
20220002378
2022-01-06

Peptides and combination of peptides for use in immunotherapy against various tumors

 #108
20210403530
2021-12-30

Peptides and combination of peptides for use in immunotherapy against various tumors

 #109
20210395338
2021-12-23

Peptides and combination of peptides for use in immunotherapy against various tumors

 #110
20210395337
2021-12-23

Peptides and combination of peptides for use in immunotherapy against various tumors

 #111
20210395336
2021-12-23

Peptides and combination of peptides for use in immunotherapy against various tumors

 #112
20210395335
2021-12-23

Peptides and combination of peptides for use in immunotherapy against various tumors

 #113
20210395334
2021-12-23

Peptides and combination of peptides for use in immunotherapy against various tumors

 #114
20210380692
2021-12-09

ANTI-TCR ANTIBODY MOLECULES AND USES THEREOF

 #115
20210355217
2021-11-18

T-cell receptor constant region 1 antibody or T-cell receptor constant region 2 antibody

 #116
20210311060
2021-10-07

METHODS, KITS, AND SYSTEMS FOR SCORING THE IMMUNE RESPONSE TO CANCER

 #117
20210300988
2021-09-30

Anti-KRAS-G12D T cell receptors

 #118
20210293812
2021-09-23

HIGH THROUGHPUT PROCESS FOR T CELL RECEPTOR TARGET IDENTIFICATION OF NATIVELY-PAIRED T CELL RECEPTOR SEQUENCES

 #119
20210263012
2021-08-26

METHODS AND COMPOSITIONS FOR MODULATING IMMUNE RESPONSES AND LYMPHOCYTE ACTIVITY

 #120
20210188944
2021-06-24

Peptides and combination of peptides for use in immunotherapy against various tumors

 #121
20210188943
2021-06-24

Peptides and combination of peptides for use in immunotherapy against various tumors

 #122
20210179691
2021-06-17

Peptides and combination of peptides for use in immunotherapy against various tumors

 #123
20210130433
2021-05-06

Anti-human papillomavirus 16 E6 T cell receptors

 #124
20210115099
2021-04-22

PEPTIDES

 #125
20210054037
2021-02-25

PEPTIDES OF PAGE5

 #126
20210054036
2021-02-25

PEPTIDES

 #127
20210011022
2021-01-14

Anti-GITR antibodies for cancer diagnostics

 #128
20210002610
2021-01-07

Methods for manufacturing T cells by direct sorting and compositions thereof

 #129
20200400680
2020-12-24

Ligand discovery for T cell receptors

 #130
20200400679
2020-12-24

Ligand discovery for T cell receptors

 #131
20200386760
2020-12-10

Prediction of response to immune-modulatory therapies

 #132
20200378969
2020-12-03

KIT FOR DETECTING SUBSET OF HUMAN REGULATORY T CELL, AND DETECTION METHOD THEREOF

 #133
20200326349
2020-10-15

Isolating Cells Expressing Secreted Proteins

 #134
20200325206
2020-10-15

Peptides and combination of peptides for use in immunotherapy against various tumors

 #135
20200316167
2020-10-08

Screening method for the identification of agents capable of activating CD4+CD25+ regulatory T-cells through interactions with the HIV-1 GP120 binding site on CD4

 #136
20200308281
2020-10-01

T cell receptor antigen binding molecules and methods of use thereof

 #137
20200308250
2020-10-01

Peptides and combination of peptides for use in immunotherapy against various tumors

 #138
20200284790
2020-09-10

BACTERIA CAUSING SEXUALLY-TRANSMITTED DISEASES AND IMMUNE T-CELL DETECTION

 #139
20200277357
2020-09-03

Citrullinated peptides that bind to types of MHC class II and their use on diagnosis and treatment

 #140
20200270329
2020-08-27

T CELL RECEPTORS RECOGNIZING MHC CLASS II-RESTRICTED MAGE-A3

 #141
20200247869
2020-08-06

Anti-KRAS-T cell receptors

 #142
20200199229
2020-06-25

Humanized or chimeric CD3 antibodies

 #143
20200123255
2020-04-23

HUMANIZED OR CHIMERIC CD3 ANTIBODIES

 #144
20200101155
2020-04-02

TOLEROGENIC SYNTHETIC NANOCARRIERS FOR GENERATING CD8+ REGULATORY T CELLS

 #145
20200101154
2020-04-02

TOLEROGENIC SYNTHETIC NANOCARRIERS FOR ANTIGEN-SPECIFIC DELETION OF T EFFECTOR CELLS

 #146
20200088726
2020-03-19

Method for high throughput peptide-MHC affinity screening for TCR ligands

 #147
20200088725
2020-03-19

Affinity-oligonucleotide conjugates and uses thereof

 #148
20200087378
2020-03-19

Relaxin1 derived peptides for use in immunotherapy

 #149
20200072834
2020-03-05

Methods for isolating target cells from blood

 #150
20200040060
2020-02-06

Peptides and combination of peptides for use in immunotherapy against various tumors

 #151
20200032208
2020-01-30

Methods of Isolating Naive Regulatory T Cells

 #152
20200031925
2020-01-30

Method for isolating HIV reservoir cells expressing CD32a cell marker

 #153
20200031899
2020-01-30

Peptides and combination of peptides for use in immunotherapy against various tumors

 #154
20200024325
2020-01-23

Peptides and combination of peptides for use in immunotherapy against various tumors

 #155
20190391148
2019-12-26

FLOW CYTOMETRY ASSAY METHODS

 #156
20190376981
2019-12-12

Isolating cells expressing secreted proteins

 #157
20190359937
2019-11-28

CHIMERIC RECEPTORS, BIOSENSOR HOST CELLS AND METHODS/USES THEREOF

 #158
20190309068
2019-10-10

Antigen binding constructs to CD3

 #159
20190309043
2019-10-10

Anti-human papillomavirus 16 E6 T cell receptors

 #160
20190300595
2019-10-03

Peptides and combination of peptides for use in immunotherapy against various tumors

 #161
20190269807
2019-09-05

SOLUBLE TCR MOLECULES AND METHODS OF USE

 #162
20190234844
2019-08-01

Chromatographic isolation of cells and other complex biological materials

 #163
20190233497
2019-08-01

HBV antigen specific binding molecules and fragments thereof

 #164
20190226951
2019-07-25

Chromatographic isolation of cells and other complex biological materials

 #165
20190219577
2019-07-18

Method for the detection of cells associated with the latent HIV viral reservoir using membrane biomarkers

 #166
20190204307
2019-07-04

Antibody-linked immuno-sedimentation agent and method of isolating a target form a sample using same

 #167
20190201443
2019-07-04

Signaling and antigen-presenting bifunctional receptors (SABR)

 #168
20190185540
2019-06-20

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

 #169
20190180439
2019-06-13

Validation methods for multiplexed imaging method

 #170
20190178886
2019-06-13

Identification of antigen epitopes and immune sequences recognizing the antigens

 #171
20190177395
2019-06-13

Anti-KRAS-G12D T cell receptors

 #172
20190119352
2019-04-25

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

 #173
20190119351
2019-04-25

Peptides and combination of peptides for use in immunotherapy against various tumors

 #174
20190076522
2019-03-14

Methods for providing polymeric synthetic nanocarriers for generating antigen-specific tolerance immune responses

 #175
20190070248
2019-03-07

Peptide mimotopes of the CD3 T-cell co-receptor epsilon chain and uses thereof

 #176
20190064170
2019-02-28

Hematopoietic cell phenotyping using circulating cell-free markers

 #177
20190025304
2019-01-24

Single cell characterization using affinity-oligonucleotide conjugates and vessel barcoded polynucleotides

 #178
20190025299
2019-01-24

High throughput process for T cell receptor target identification of natively-paired T cell receptor sequences

 #179
20190023762
2019-01-24

Peptides and combination of peptides for use in immunotherapy against various tumors

 #180
20190002524
2019-01-03

Peptides and combination of peptides for use in immunotherapy against various tumors

 #181
20180372744
2018-12-27

Methods for determining the risk of cardiovascular disease in a subject having a chronic viral infection through the measurement of lysophosphatidic acid

 #182
20180371050
2018-12-27

Murine anti-NY-ESO-1 T cell receptors

 #183
20180371040
2018-12-27

PEPTIDES OF PAGE5

 #184
20180371039
2018-12-27

PEPTIDES

 #185
20180356424
2018-12-13

MHC-bound peptide arrays and methods of use thereof

 #186
20180346576
2018-12-06

Methods for diagnosing and treating inflammatory bowel disease

 #187
20180346548
2018-12-06

Peptides and combination of peptides for use in immunotherapy against various tumors

 #188
20180340019
2018-11-29

Peptides and combination of peptides for use in immunotherapy against various tumors

 #189
20180327475
2018-11-15

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

 #190
20180258155
2018-09-13

RELAXIN1 derived peptides for use in immunotherapy against various tumors

 #191
20180251518
2018-09-06

Peptides and combination of peptides for use in immunotherapy against various tumors

 #192
20180251517
2018-09-06

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

 #193
20180244746
2018-08-30

T cell receptors (TCR) and uses thereof for the diagnosis and treatment of diabetes

 #194
20180237520
2018-08-23

Method for generating antibodies against T cell receptor

 #195
20180237494
2018-08-23

Peptides and combination of peptides for use in immunotherapy against various tumors

 #196
20180237493
2018-08-23

Peptides and combination of peptides for use in immunotherapy against various tumors

 #197
20180230195
2018-08-16

Peptides and combination of peptides for use in immunotherapy against various tumors

 #198
20180230194
2018-08-16

Peptides and combination of peptides for use in immunotherapy against various tumors

 #199
20180208641
2018-07-26

Peptides and combination of peptides for use in immunotherapy against various tumors

 #200
20180208640
2018-07-26

Peptides and combination of peptides for use in immunotherapy against various tumors

 #201
20180164321
2018-06-14

Anti-GITR antibodies for cancer diagnostics

 #202
20180164287
2018-06-14

Methods and compositions for obtaining a tuberculosis assessment in a subject

 #203
20180164282
2018-06-14

Methods of diagnosing infection or recurrence in a subject

 #204
20180141993
2018-05-24

Peptides and combination of peptides for use in immunotherapy against various tumors

 #205
20180127479
2018-05-10

T cell receptors recognizing MHC class II-restricted MAGE-A3

 #206
20180106816
2018-04-19

Multiples multiplex immunohistochemical assay using primary antibodies of the same host species

 #207
20180106779
2018-04-19

Methods and kits for labeling, detection and isolation of Foxp3 regulatory T cells, isolated population of Foxp3 regulatory T cells thus obtained and uses thereof

 #208
20180100005
2018-04-12

Peptides and combination of peptides for use in immunotherapy against various tumors

 #209
20180094043
2018-04-05

Peptides and combination of peptides for use in immunotherapy against various tumors

 #210
20180094041
2018-04-05

Anti-human papillomavirus 16 E6 T cell receptors

 #211
20180088121
2018-03-29

T cell receptors and peptides derived by mutations for the treatment of cancer

 #212
20180080078
2018-03-22

Method of identifying human compatible T cell receptors specific for an antigenic target

 #213
20180042995
2018-02-15

Methods of making and using soluble MHC molecules

 #214
20180038863
2018-02-08

COMMON CAPTURE CELL SEPARATIONS DONE VIA SIMULTANEOUS INCUBATION OF COMPONENTS

 #215
20180037629
2018-02-08

Peptides and combination of peptides for use in immunotherapy against various tumors

 #216
20180037628
2018-02-08

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

 #217
20180037627
2018-02-08

Peptides and combination of peptides for use in immunotherapy against various tumors

 #218
20180037626
2018-02-08

Peptides and combination of peptides for use in immunotherapy against various tumors

 #219
20180030113
2018-02-01

Peptides and combination of peptides for use in immunotherapy against various tumors

 #220
20170370932
2017-12-28

CD247 as a biomarker for assessing the effect of chemotherapeutic and biological drugs

 #221
20170362298
2017-12-21

Enhanced affinity T cell receptors and methods for making the same

 #222
20170334998
2017-11-23

CHIMERIC ANTIGEN RECEPTOR (CAR) WITH ANTIGEN BINDING DOMAINS TO THE T CELL RECEPTOR BETA CONSTANT REGION

 #223
20170313760
2017-11-02

Peptides and combination of peptides for use in immunotherapy against various tumors

 #224
20170305993
2017-10-26

Peptides and combination of peptides for use in immunotherapy against various tumors

 #225
20170305992
2017-10-26

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

 #226
20170268056
2017-09-21

Methods of selecting T cell receptors using affinity oligonucleotide conjugates

 #227
20170240884
2017-08-24

IDENTIFICATION OF T CELL TARGET ANTIGENS

 #228
20170234886
2017-08-17

Multiplex immunohistochemical assay using primary antibodies of the same host species

 #229
20170192011
2017-07-06

Ligand discovery for T cell receptors

 #230
20170158750
2017-06-08

Peptides and combination of peptides for use in immunotherapy against various tumors

 #231
20170145073
2017-05-25

Peptides and combination of peptides for use in immunotherapy against various tumors

 #232
20170145072
2017-05-25

Peptides and combination of peptides for use in immunotherapy against various tumors

 #233
20170097361
2017-04-06

METHOD AND DEVICE FOR STABILIZING OF PROTEINS

 #234
20170097333
2017-04-06

CELL BASED ASSAY TO MEASURE THE T-CELL STIMULATING CAPACITY OF ANTI-LAG3 ANTIBODIES AND OTHER AGENTS

 #235
20170089885
2017-03-30

CELL LINE-BASED REDIRECTED T-CELL CYTOTOXICITY ASSAY

 #236
20170066827
2017-03-09

CHIMERIC ANTIGEN RECEPTOR

 #237
20170044500
2017-02-16

APPLICATION OF INDUCED PLURIPOTENT STEM CELLS TO GENERATE ADOPTIVE CELL THERAPY PRODUCTS

 #238
20170029483
2017-02-02

Murine anti-NY-ESO-1 T cell receptors

 #239
20170023567
2017-01-26

Identification of antigen epitopes and immune sequences recognizing the antigens

 #240
20170014474
2017-01-19

Screening method for the identification of agents capable of activating CD4+CD25+ regulatory T-cells through interactions with the HIV-1 GP120 binding site on CD4

 #241
20160363593
2016-12-15

Methods, kits, and systems for scoring the immune response to cancer

 #242
20160333095
2016-11-17

Humanized or chimeric CD3 antibodies

 #243
20160282346
2016-09-29

Blood analyzer and blood analysis method

 #244
20160280760
2016-09-29

Peptides and combination of peptides for use in immunotherapy against various tumors

 #245
20160280759
2016-09-29

Peptides and combination of peptides for use in immunotherapy against various tumors

 #246
20160280758
2016-09-29

Peptides and combination of peptides for use in immunotherapy against various tumors

 #247
20160280757
2016-09-29

Peptides and combination of peptides for use in immunotherapy against various tumors

 #248
20160280752
2016-09-29

Peptides and combination of peptides for use in immunotherapy against various tumors

 #249
20160280738
2016-09-29

Peptides and combination of peptides for use in immunotherapy against various tumors

 #250
20160279234
2016-09-29

Tolerogenic synthetic nanocarriers for allergy therapy

 #251
20160279217
2016-09-29

Peptides and combination of peptides for use in immunotherapy against various tumors

 #252
20160279216
2016-09-29

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

 #253
20160279214
2016-09-29

Peptides and combination of peptides for use in immunotherapy against various tumors

 #254
20160243253
2016-08-25

Tolerogenic synthetic nanocarriers

 #255
20160238597
2016-08-18

Quantification of antigen molecules using dynamic flow cytometry

 #256
20160231322
2016-08-11

Immunohistochemical assay for detection of CD3 and CD16

 #257
20160209424
2016-07-21

Kit for diagnosis, prognosis, and monitoring the immune status, of patients with chronic inflammatory diseases

 #258
20160195531
2016-07-07

Correlation of disease activity with clonal expansions of human papillomavirus 16-specific CD8+ T-cells in patients with severe erosive oral lichen planus

 #259
20160193369
2016-07-07

MAGNETIC NANOPARTICLE AND METHOD FOR IMAGING T CELLS

 #260
20160169869
2016-06-16

SYSTEMS AND METHODS FOR ASSESSING MODULATORS OF IMMUNE CHECKPOINTS

 #261
20160168247
2016-06-16

Humanized or chimeric CD3 antibodies

 #262
20160152681
2016-06-02

Anti-human papillomavirus 16 E6 T cell receptors

 #263
20160130323
2016-05-12

Complexes of types of MHC class II that bind to collagen type II peptides and their use on diagnosis and treatment

 #264
20160123985
2016-05-05

Hematopoietic cell phenotyping using circulating cell-free markers

 #265
20160120908
2016-05-05

Application of mesenchymal stem cells in prophylaxis or treatment of stress response-induced weakened immunity

 #266
20160115479
2016-04-28

Predictive biomarker for cancer therapy

 #267
20160097770
2016-04-07

METHODS FOR DIAGNOSIS, PROGNOSIS AND METHODS OF TREATMENT

 #268
20160091491
2016-03-31

METHODS FOR DIAGNOSIS OF CELIAC DISEASE

 #269
20160041164
2016-02-11

Anti-lymphocyte autoantibodies as diagnostic biomarkers

 #270
20160033530
2016-02-04

Isolating cells expressing secreted proteins

 #271
20160030555
2016-02-04

Tolerogenic synthetic nanocarriers for generating CD8+ regulatory T cells

 #272
20160030439
2016-02-04

Methods for the treatment of autoimmune diseases

 #273
20150337384
2015-11-26

IN VITRO METHOD FOR THE DIAGNOSIS AND SURVEILLANCE OF CANCER

 #274
20150320884
2015-11-12

Tolerogenic synthetic nanocarriers for antigen-specific deletion of T effector cells

 #275
20150320856
2015-11-12

Method for providing polymeric synthetic nanocarriers for generating antigen-specific tolerance immune responses

 #276
20150313977
2015-11-05

IMMUNOGENIC FRAGMENTS OF T-CELL RECEPTOR CONSTANT DOMAINS AND PEPTIDES DERIVED THEREFROM

 #277
20150307611
2015-10-29

Methods for diagnosing and treating inflammatory bowel disease

 #278
20150301022
2015-10-22

Methods for determining the risk of acute graft versus host disease

 #279
20150292034
2015-10-15

Receptor gene for peptide cancer antigen-specific T cell

 #280
20150246959
2015-09-03

T cell receptors recognizing MHC class II-restricted MAGE-A3

 #281
20150232529
2015-08-20

High Affinity TCR Proteins and Methods

 #282
20150226743
2015-08-13

MULTIPLEXED METHOD FOR DIAGNOSING CLASSICAL HODGKIN LYMPHOMA

 #283
20150202230
2015-07-23

LAT adapter molecule for enhanced T-cell signaling and method of use

 #284
20150141347
2015-05-21

Murine anti-NY-ESO-1 T cell receptors

 #285
20150118252
2015-04-30

Antigen binding constructs to CD3

 #286
20150118208
2015-04-30

Enhanced affinity T cell receptors and methods for making the same

 #287
20150044252
2015-02-12

Correlation of disease activity with clonal expansions of human papillomavirus 16-specific CD8+ T-cells in patients with severe erosive oral lichen planus

 #288
20150024411
2015-01-22

Chromatographic isolation of cells and other complex biological materials

 #289
20150011418
2015-01-08

METHOD FOR DETERMINING THE IMMUNE STATUS OF A SUBJECT

 #290
20140378656
2014-12-25

Soluble TCR molecules and methods of use

 #291
20140371090
2014-12-18

Method and kit for determining-antibody sensitivity and clone cell strain

 #292
20140363472
2014-12-11

Methods for predicting the survival time of a patient suffering from a solid cancer based on density of B cells

 #293
20140336078
2014-11-13

High throughput sensitization detection devices and methods

 #294
20140323333
2014-10-30

Flow cytometry assay methods

 #295
20140255941
2014-09-11

Receptor gene for peptide cancer antigen-specific T cell

 #296
20140227256
2014-08-14

Predictive biomarker for cancer treatment with ADCC-enhanced antibodies

 #297
20140199340
2014-07-17

Tolerogenic synthetic nanocarriers for inducing regulatory B cells

 #298
20140017695
2014-01-16

Isolating cells expressing secreted proteins

 #299
20130330325
2013-12-12

Means and methods for the prediction of treatment response of a cancer patient

 #300
20130195900
2013-08-01

Identification of T cell target antigens